Literature DB >> 20802483

Structural insights into the assembly and activation of IL-1β with its receptors.

Dongli Wang1, Senyan Zhang, Liang Li, Xi Liu, Kunrong Mei, Xinquan Wang.   

Abstract

Interleukin 1β (IL-1β) is a key orchestrator of inflammation and host defense that exerts its effects through IL-1 receptor type I (IL-1RI) and IL-1 receptor accessory protein (IL-1RAcP). How IL-1RAcP is recruited by IL-1β-IL-1RI to form the signaling-competent complex remains elusive. Here we present the crystal structure of IL-1β bound to IL-1 receptor type II (IL-1RII) and IL-1RAcP. IL-1β-IL-1RII generated a composite binding surface to recruit IL-1RAcP. Biochemical analysis demonstrated that IL-1β-IL-1RI and IL-1β-IL-1RII interacted similarly with IL-1RAcP. It also showed the importance of two loops of IL-1 receptor antagonist (IL-1Ra) in determining its antagonism. Our results provide a structural basis for assembly and activation of the IL-1 receptor and offer a general cytokine-receptor architecture that governs the IL-1 family of cytokines.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20802483     DOI: 10.1038/ni.1925

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  53 in total

1.  Structural requirements of six naturally occurring isoforms of the IL-18 binding protein to inhibit IL-18.

Authors:  S H Kim; M Eisenstein; L Reznikov; G Fantuzzi; D Novick; M Rubinstein; C A Dinarello
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

2.  Substructure solution with SHELXD.

Authors:  Thomas R Schneider; George M Sheldrick
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2002-09-28

3.  Structure-activity relationships in human interleukin-1 alpha: identification of key residues for expression of biological activities.

Authors:  H Kawashima; J Yamagishi; M Yamayoshi; M Ohue; T Fukui; H Kotani; M Yamada
Journal:  Protein Eng       Date:  1992-03

4.  cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily.

Authors:  J E Sims; C J March; D Cosman; M B Widmer; H R MacDonald; C J McMahan; C E Grubin; J M Wignall; J L Jackson; S M Call
Journal:  Science       Date:  1988-07-29       Impact factor: 47.728

5.  A new cytokine-receptor binding mode revealed by the crystal structure of the IL-1 receptor with an antagonist.

Authors:  H Schreuder; C Tardif; S Trump-Kallmeyer; A Soffientini; E Sarubbi; A Akeson; T Bowlin; S Yanofsky; R W Barrett
Journal:  Nature       Date:  1997-03-13       Impact factor: 49.962

6.  Functional epitope mapping of human interleukin-1 beta by surface plasmon resonance.

Authors:  C D'Ettorre; G De Chiara; R Casadei; D Boraschi; A Tagliabue
Journal:  Eur Cytokine Netw       Date:  1997-06       Impact factor: 2.737

7.  Structure of IL-33 and its interaction with the ST2 and IL-1RAcP receptors--insight into heterotrimeric IL-1 signaling complexes.

Authors:  Andreas Lingel; Thomas M Weiss; Marc Niebuhr; Borlan Pan; Brent A Appleton; Christian Wiesmann; J Fernando Bazan; Wayne J Fairbrother
Journal:  Structure       Date:  2009-10-14       Impact factor: 5.006

8.  Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4.

Authors:  F Colotta; F Re; M Muzio; R Bertini; N Polentarutti; M Sironi; J G Giri; S K Dower; J E Sims; A Mantovani
Journal:  Science       Date:  1993-07-23       Impact factor: 47.728

9.  The structure and binding mode of interleukin-18.

Authors:  Zenichiro Kato; JunGoo Jee; Hiroaki Shikano; Masaki Mishima; Izuru Ohki; Hidenori Ohnishi; Ailian Li; Kazuyuki Hashimoto; Eiji Matsukuma; Kentaro Omoya; Yutaka Yamamoto; Teruyo Yoneda; Takane Hara; Naomi Kondo; Masahiro Shirakawa
Journal:  Nat Struct Biol       Date:  2003-10-05

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  67 in total

1.  Accessory to inflammation.

Authors:  John E Sims
Journal:  Nat Immunol       Date:  2010-10       Impact factor: 25.606

Review 2.  Structural insights into the assembly of large oligomeric signalosomes in the Toll-like receptor-interleukin-1 receptor superfamily.

Authors:  Ryan Ferrao; Jixi Li; Elisa Bergamin; Hao Wu
Journal:  Sci Signal       Date:  2012-05-29       Impact factor: 8.192

3.  IL-1 receptor accessory protein-Ig/IL-1 receptor type II-Ig heterodimer inhibits IL-1 response more strongly than other IL-1 blocking biopharmaceutical agents.

Authors:  Haruo Hanawa; Yoshimi Ota; Limin Ding; He Chang; Kaori Yoshida; Keita Otaki; Kazuhisa Hao; Sou Kasahara; Makoto Kodama; Mikio Nakazawa; Yoshifusa Aizawa
Journal:  J Clin Immunol       Date:  2010-12-22       Impact factor: 8.317

Review 4.  The interleukin-1 family: back to the future.

Authors:  Cecilia Garlanda; Charles A Dinarello; Alberto Mantovani
Journal:  Immunity       Date:  2013-12-12       Impact factor: 31.745

5.  Quantitative ligand and receptor binding studies reveal the mechanism of interleukin-36 (IL-36) pathway activation.

Authors:  Li Zhou; Viktor Todorovic; Steve Kakavas; Bernhard Sielaff; Limary Medina; Leyu Wang; Ramkrishna Sadhukhan; Henning Stockmann; Paul L Richardson; Enrico DiGiammarino; Chaohong Sun; Victoria Scott
Journal:  J Biol Chem       Date:  2017-11-27       Impact factor: 5.157

6.  Design of a superior cytokine antagonist for topical ophthalmic use.

Authors:  Jinzhao Hou; Sharon A Townson; Joseph T Kovalchin; Allyson Masci; Olga Kiner; Yanqun Shu; Bracken M King; Emily Schirmer; Kathryn Golden; Christoph Thomas; K Christopher Garcia; Gregory Zarbis-Papastoitsis; Eric S Furfine; Thomas M Barnes
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-19       Impact factor: 11.205

7.  A Whole Methylome CpG-SNP Association Study of Psychosis in Blood and Brain Tissue.

Authors:  Edwin J C G van den Oord; Shaunna L Clark; Lin Ying Xie; Andrey A Shabalin; Mikhail G Dozmorov; Gaurav Kumar; Vladimir I Vladimirov; Patrik K E Magnusson; Karolina A Aberg
Journal:  Schizophr Bull       Date:  2015-12-09       Impact factor: 9.306

8.  Allosteric switching of agonist/antagonist activity by a single point mutation in the interluekin-1 receptor antagonist, IL-1Ra.

Authors:  Kendra L Hailey; Dominique T Capraro; Sulyman Barkho; Patricia A Jennings
Journal:  J Mol Biol       Date:  2013-03-15       Impact factor: 5.469

Review 9.  Molecular basis of NF-κB signaling.

Authors:  Johanna Napetschnig; Hao Wu
Journal:  Annu Rev Biophys       Date:  2013-03-11       Impact factor: 12.981

10.  The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1β.

Authors:  Jean-Michel Rondeau; Paul Ramage; Mauro Zurini; Hermann Gram
Journal:  MAbs       Date:  2015-08-18       Impact factor: 5.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.